Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 5.1.1, then the royalty rate to be paid by ACORDA on Net Sales in that country under Section 5.1.1 shall be reduced to the rate paid by the compulsory Third Party licensee.
Appears in 4 contracts
Samples: License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc)
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 5.1.15.3.1 (as adjusted pursuant to Section 5.3.3), then the royalty rate to be paid by ACORDA Celgene on Per Licensed Product Annual Net Sales in that such country under Section 5.1.1 5.3.1 shall be reduced to the rate paid by the compulsory Third Party licensee[***].
Appears in 4 contracts
Samples: Global License Agreement (Prothena Corp Public LTD Co), Master Collaboration Agreement, Master Collaboration Agreement (Prothena Corp PLC)
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 5.1.15.2.1 (as adjusted pursuant to Section 5.2.3), then the royalty rate to be paid by ACORDA Celgene on Per Licensed Product Annual Net Sales in that country under Section 5.1.1 5.2.1 shall be reduced to the rate paid by the compulsory Third Party licensee[***].
Appears in 3 contracts
Samples: Master Collaboration Agreement, Master Collaboration Agreement (Prothena Corp PLC), Master Collaboration Agreement (Prothena Corp PLC)
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to any Initial Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 5.1.17.4.1 (as adjusted pursuant to Section 7.4.3), then the royalty rate to be paid by ACORDA Celgene on Per Initial Licensed Product Annual Net Sales in that such country under Section 5.1.1 7.4.1 shall be reduced to the rate paid payable by the compulsory Third Party licensee.
Appears in 1 contract
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Licensed Product in any country in the Territory with a royalty rate lower than the royalty rate provided by Section 5.1.15.2.1 (as adjusted pursuant to Section 5.2.3), then the royalty rate to be paid by ACORDA Celgene on Per Licensed Product Annual Net Sales in that country under Section 5.1.1 5.2.1 shall be reduced to the rate paid by the compulsory Third Party licensee[***].
Appears in 1 contract
Compulsory Licenses. If a compulsory license is granted to a Third Party with respect to a Licensed Product in any country in the Celgene Territory with a royalty rate lower * Confidential Information, indicated by [...***...], has been omitted from this filing and filed separately with the U.S. Securities and Exchange Commission. 55 than the royalty rate provided by Section 5.1.18.6.1 (as adjusted per Section 8.6.3), then the royalty rate to be paid by ACORDA Celgene on Per Licensed Product Annual Net Sales under such compulsory license in that such country under Section 5.1.1 shall 8.6.1 will be reduced to the rate paid payable by the compulsory Third Party licensee.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (BeiGene, Ltd.)